Cytokinetics, Inc. (CYTK)
76.94
-1.12
(-1.43%)
USD |
NASDAQ |
May 22, 16:00
76.91
-0.03
(-0.04%)
Pre-Market: 20:00
Cytokinetics Total Liabilities (Quarterly) : 2.100B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | 3.640B |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| BioMarin Pharmaceutical, Inc. | 2.379B |
| Ionis Pharmaceuticals, Inc. | 2.959B |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.273B |
| Shareholders Equity (Quarterly) | -826.57M |
| Debt to Equity Ratio | -1.559 |
| Current Ratio | 4.214 |
| Net Debt Paydown Yield | -1.22% |